c.espinoza
Submits third-party assay reports on material purchased directly. Based in Kumasi.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.91%
n=8
Suppliers covered
9
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042636 | IGF-1 LR3 | GGPeps | GGPE-2604-K8140 | Janoshik | 2026-Q2 | 98.39 | 2.26 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041435 | BPC-157 | QYB | QYB-2601-D4733 | Janoshik | 2026-Q2 | 99.93 | 3.77 | 96.6 | Supplier-supplied | 0 | PASS |
| AX-2026-041230 | L-Glutathione (reduced) | WWB | WWB-2602-U1840 | PeptideMeter | 2026-Q1 | 98.71 | 9.22 | 94.2 | Laboratory-retained | 0 | PASS |
| AX-2025-020924 | Thymalin | CPC | CPC-2501-V3057 | Janoshik | 2025-Q1 | N/A | 6.88 | — | Supplier-supplied | 0 | N/A |
| AX-2025-019743 | Selank | HJ | HJ-2501-M3464 | Janoshik | 2025-Q1 | 99.57 | 7.80 | 99.5 | Supplier-supplied | 0 | PASS |
| AX-2025-019031 | Leuprolide | JEEP | JEEP-2408-K3061 | PeptideMeter | 2024-Q4 | 99.06 | 4.69 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004383 | Semaglutide | QSC | QSC-2410-P7940 | VendorInvestigate | 2024-Q4 | 98.77 | 5.02 | 100.1 | Buyer-sourced | 2 | MARGINAL |
| AX-2024-004719 | Semaglutide | Homopeptide | HOMO-2401-R8471 | Medutest | 2024-Q2 | 99.93 | 1.99 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005521 | Afamelanotide | BCH | BCH-2310-K7610 | Janoshik | 2024-Q1 | 97.97 | 4.33 | — | Supplier-supplied | 0 | FAIL |